Medications

MDMA-Assisted Psychotherapy Shows Promise in Treatment for Alcohol Addiction
MDMA-assisted psychotherapy for the treatment of alcohol use disorder was found to improve psychosocial functioning with no unexpected adverse events in a clinical trial conducted by London-based Awakn Life Sciences.
Low-Dose Naltrexone Used as Alternative to Opioids for Chronic Pain Patients
A low dose of naltrexone was found to be a promising alternative to opioids prescribed for patients with orofacial and chronic pain, according to a new study from the University of Michigan School of Dentistry.
Inconsistent Prescribing of Anti-Anxiety Meds a Concern During—and After—Pandemic
With drug overdose deaths reaching historic levels during the COVID-19 pandemic, researchers from the Lerner Center for Public Health Promotion at Syracuse University noted how inconsistent prescribing of anti-anxiety medications has been a significant contributing factor and will continue to be post-pandemic.
Indiana University Researchers to Study Use of Tezampanel for Opioid Withdrawal
The Indiana University School of Medicine has received a $12.3 million grant from the National Institute on Drug Abuse for a two-stage research project to study the use of tezampanel to treat opioid withdrawal syndrome, as well as other addictions and mental illnesses.
Overdose Prevention Group, Emergent BioSolutions, MLB Clubs Join Forces on Campaign
Not-for-profit organization Mothers Against Prescription Drug Abuse, life sciences firm Emergent BioSolutions, and three Major League Baseball clubs team up for Overdose Awareness Day initiative.
Report: Researchers Studying Naltrexone for Treatment of COVID-19 Symptoms
Researchers from Beaumont Health System in Michigan are studying whether naltrexone can be used to help manage symptoms of individuals with a COVID-19 infection, according to a report from Detroit’s NPR affiliate.
Buprenorphine Analog Shows Potential for Treating Cocaine Addiction in Study
In a study of mice, a buprenorphine analog was found to be more effective at activating receptors that prevent cocaine relapse without increasing addiction potential, according to a Science Magazine report.
Lofexidine Demonstrates Efficacy During Early Opioid Withdrawal
SAN DIEGO—The opioid withdrawal drug lofexidine demonstrated statistically significant efficacy across a half-dozen patient- and clinician-reported outcomes during the first 7 days after immediate opioid cessation, according to study presented at…
Managing Patients With Opioid Use Disorder and Chronic Pain
SAN DIEGO—Mental health clinicians will likely be taking on many more patients with opioid use disorder, as 40% of primary care providers will not accept any new patients who take opioids, an expert said at Psych Congress 2019.
Panelists: MAT is Not a Harm Reduction Strategy; Syringe Exchanges Working as Intended
There was universal agreement among panelists during a Sunday morning session at the National Conference on Addiction Disorders East about the benefits of harm reduction strategies. They prevent overdose deaths and the spread of infectious diseases…
Back to Top